Management and Treatment of Cancer Patients with Chemotherapy Induced Nausea and Vomiting


This activity is an archive of the live session held at the 2009 Fall Managed Care Forum. If you participated in the live activity, you are not eligible for continuing education credits from this archive.

This activity is valid from September 1, 2010 to December 31, 2011.
These presentations require Internet Explorer 5.0 or later, Netscape Navigator 7.0 or later, or Internet Explorer 5.2.2 for Mac.  To Download the latest version of Internet Explorer from the Microsoft web site, click here.

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This activity is supported by an educational grant from Eisai Inc.

PLEASE CLICK HERE TO VIEW PRESENTATION

 PLEASE CLICK HERE FOR POST TEST AND EVALUATION

Instructions for CME/CEU:  View the presentation, answer the post test, complete the evaluation form and submit.  A score of 70% must be achieved on the post test to receive continuing education credits. You will have the option on the post test/evaluation page to submit your forms electronically or by faxing them to Katie Eads at 804-747-5316.

Description
It is thought that 60%-80% of cancer patients who do not receive any type of prophylactic antiemetics experience some form of CINV. The risk of developing CINV in some form is affected by patient related factors and treatment related factors. Some patient factors which are associated with a higher risk of CINV include female gender, age being greater than 50, lower chronic alcohol intake, no tobacco use, and prior episodes of CINV. One or two episodes can have a dramatic effect on the quality of life in cancer patients. Patients who encounter CINV often delay or postpone their next chemotherapy treatments. It is crucial to educate physicians and nurses on the ways to manage CINV and the latest treatments that have become available.

Upon Completion of this activity, participants will be able to:

  • Describe the different types of CINV (acute, delayed and anticipatory)

  • Review NCCN Guidelines on antiemesis in cancer patients

  • Discuss available treatment options for CINV

  • Identify the goals of managing the CINV patient population

  • Describe the risks and consequences that can result from non-compliance and/or untreated CINV
     

Faculty: Susan Urba, MD
Professor, Department of Internal Medicine
University of Michigan
Comprehensive Cancer Center

Disclosure:

 Dr. Urba has no financial relationships that present a real or perceived conflict of interest.
  Planning Committee:
Bill Williams, MD has no real or perceived financial relationships to disclose.
Katie Eads has no real or perceived financial relationships to disclose.
  NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. NAMCP designates this activity for a maximum of 1 AMA PRA Category I creditsTM.  Each physician should claim credit commensurate with the extent of their participation in the activity.

The American Association of Managed Care Nurses (AAMCN) has been approved as a provider of continuing education by the Virginia Nurses Association (VNA).  VNA is accredited as an approver of continuing education in nursing by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses who complete this activity will be awarded 1 contact hours.

This activity has been approved by the American Board of Managed Care Nursing for 1 contact hours toward CMCN recertification requirements.
   

This activity is supported by an educational grant from Eisai Inc.

NAMCP and or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.